The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution - PubMed (original) (raw)

Comparative Study

. 1997 Dec 12;274(4):661-75.

doi: 10.1006/jmbi.1997.1396.

Affiliations

• PMID: 9417943
• DOI: 10.1006/jmbi.1997.1396

Comparative Study

The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution

W Klaus et al. J Mol Biol. 1997.

Abstract

The solution structure of recombinant human interferon alpha-2a (Roferon-A) has been determined by multidimensional heteronuclear NMR spectroscopy. The calculations using simulated annealing produced a family of 24 convergent structures which satisfy the experimental restraints comprising 1541 NOE-derived inter-proton distances, 187 dihedral restraints, 66 pairs of hydrogen bond restraints, and six upper and lower limits for two disulfide bridges. The fractional labeling of methyl groups allowed their direct and unambiguous stereospecific assignment which proved to be essential for obtaining a high resolution of the structures. A best fit superposition of residues 10 to 47, 50 to 101 and 111 to 157 gives an rms deviation of 0.62 A for the backbone heavy atoms and 1.39 A for all heavy atoms of these segments. The dominant feature of the structure is a cluster of five alpha-helices, four of which are arranged to form a left-handed helix bundle with an up-up-down-down topology and two over-hand connections. The interpretation of heteronuclear 15N-¿1H¿ NOE data shows the co-existence of flexible regions within an otherwise rigid framework of the protein. Four stretches of pronounced flexibility can be located: Cys1-Ser8, Gly44-Ala50, Ile100-Lys112, and Ser160-Glu165. Among the structurally related four-helical bundle cytokines, the structure of IFN alpha-2a is most similar to that of human interferon alpha-2b and murine interferon-beta. From this structural information and mutagenesis data, areas on the surface of the protein are identified which seem to be important in receptor interactions.

PubMed Disclaimer

Similar articles

• The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy.
  Powers R, Garrett DS, March CJ, Frieden EA, Gronenborn AM, Clore GM. Powers R, et al. Biochemistry. 1993 Jul 6;32(26):6744-62. doi: 10.1021/bi00077a030. Biochemistry. 1993. PMID: 8329398
• Three-dimensional solution structure and backbone dynamics of a variant of human interleukin-3.
  Feng Y, Klein BK, McWherter CA. Feng Y, et al. J Mol Biol. 1996 Jun 14;259(3):524-41. doi: 10.1006/jmbi.1996.0337. J Mol Biol. 1996. PMID: 8676386
• Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.
  Kraulis PJ, Domaille PJ, Campbell-Burk SL, Van Aken T, Laue ED. Kraulis PJ, et al. Biochemistry. 1994 Mar 29;33(12):3515-31. doi: 10.1021/bi00178a008. Biochemistry. 1994. PMID: 8142349
• Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon-beta.
  Mitsui Y, Senda T, Shimazu T, Matsuda S, Utsumi J. Mitsui Y, et al. Pharmacol Ther. 1993;58(1):93-132. doi: 10.1016/0163-7258(93)90068-o. Pharmacol Ther. 1993. PMID: 8415875 Review.
• The structure of human interferon-beta: implications for activity.
  Karpusas M, Whitty A, Runkel L, Hochman P. Karpusas M, et al. Cell Mol Life Sci. 1998 Nov;54(11):1203-16. doi: 10.1007/s000180050248. Cell Mol Life Sci. 1998. PMID: 9849615 Free PMC article. Review.

Cited by

• Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY.
  Nudelman I, Akabayov SR, Schnur E, Biron Z, Levy R, Xu Y, Yang D, Anglister J. Nudelman I, et al. Biochemistry. 2010 Jun 29;49(25):5117-33. doi: 10.1021/bi100041f. Biochemistry. 2010. PMID: 20496919 Free PMC article.
• Effects of localized interactions and surface properties on stability of protein-based therapeutics.
  Mills BJ, Laurence Chadwick JS. Mills BJ, et al. J Pharm Pharmacol. 2018 May;70(5):609-624. doi: 10.1111/jphp.12658. Epub 2016 Nov 10. J Pharm Pharmacol. 2018. PMID: 27861887 Free PMC article. Review.
• Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation.
  Castro LS, Lobo GS, Pereira P, Freire MG, Neves MC, Pedro AQ. Castro LS, et al. Vaccines (Basel). 2021 Apr 1;9(4):328. doi: 10.3390/vaccines9040328. Vaccines (Basel). 2021. PMID: 33915863 Free PMC article. Review.
• Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.
  Piehler J, Thomas C, Garcia KC, Schreiber G. Piehler J, et al. Immunol Rev. 2012 Nov;250(1):317-34. doi: 10.1111/imr.12001. Immunol Rev. 2012. PMID: 23046138 Free PMC article. Review.
• Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-interferon antibody fragment and human interferon alpha-2A.
  Oganesyan V, Damschroder MM, Cook KE, Wu H, Dall'Acqua WF. Oganesyan V, et al. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jan 1;65(Pt 1):14-6. doi: 10.1107/S1744309108037925. Epub 2008 Dec 25. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009. PMID: 19153447 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • GlyGen glycoinformatics resource